Faculty Publications

As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.

Total number of publications: 7,082

Enter a faculty name:

or browse faculty by school:

Administrative Offices

Graduate Schools

Health Sciences

Lander Colleges

Law Center

New York School of Career and Applied Studies (NYSCAS)

Touro University System

Reset
First Prev 1 2 Next Last

  • Peng, G. A., Sohal, A., Pinizzotto, J., & Elul, T. (2015). Roles of APC N-terminal and central domains in optic axon pathfinding and arborization in vivo. Journal of the American Osteopathic Association, 115(12), e49-e50. This material can be found here.

  • Pick, C. G., Peter, Y., Paz, L., Schreiber, S., Gavish, M., & Weizman, R. (1997). Effect of the pregnane-related GABA-active steroid alphaxalone on mice performance in the staircase test. Brain Research, 765(1), 129-134. doi:10.1016/S0006-8993(97)00540-4

    		•

  • Pick, C. G., Peter, Y., Schreiber, S., & Weizman, R. (1997). Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with κ3 analgesia. Brain Research, 744(1), 41-46. doi:10.1016/S0006-8993(96)01069-4

    		•

  • Pick, C. G., Peter, Y., Terkel, J., Gavish, M., & Weizman, R. (1996). Effect of the neuroactive steroid α-THDOC on staircase test behavior in mice. Psychopharmacology, 128(1), 61-66. doi:10.1007/s002130050110

    		•

  • Pinkhasov, A., Lam, T., Hayes, D., Friedman, N., Singh, D., & Cohen, H. (2015). Lacosamide induced psychosis: Case report, review of differential diagnosis and relevant pharmacokinetics. Clinical Neuropharmacology, 38(5), 198-200. doi:10.1097/WNF.0000000000000097

    		•

  • Robson, M. J., Turner, R. C., Naser, Z. J., McCurdy, C. R., O'Callaghan, J. P., Huber, J. D., & Matsumoto, R. R. (2014). SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental Neurology, 254, 180-189. doi:10.1016/j.expneurol.2014.01.020

    		•

  • Singh, U., Gill, M., Rice, R., Dimaano, F., Warburton, A., & Wells, M. R. (2016). Time of day and performance on cognitive tests in patients with mild dementia. HSOA Journal of Alzheimer’s and Neurodegenerative Diseases, 2(1) [Article 003]. This material can be found here.

  • Sohal, A., Ha, J., Zhu, M., Lakhani, F., Olszewski, L., Mohanakrishnan, R., . . . Elul, T. (2017). Morphometrics in developmental neurobiology: Quantitative analysis of growth cone motility in vivo. In P. M. Pares-Casanova (Ed.), New insights into morphometry studies (pp. 31-45). Rijeka, Croatia: IN TECH. This material can be found here.

  • Steinman, G. D. (2015). Plausible etiology of brain dysconnectivity in autism – Review and prospectus. Medical Hypotheses, 85(4), 405-407. doi:10.1016/j.mehy.2015.06.018

    		•

  • Steinman, G. D. (2017). A new pharmacologic approach for the potential reduction of autism and multiple sclerosis. Scientific Pages of Pediatric Neurology, 1(1), 1-5. This material can be found here.

  • Strand, F. L., Lee, S. J., Lee, T. S., Zuccarelli, L. A., Antonawich, F. J., Kume, J., & Williams, K. A. (1993). Non-corticotropic ACTH peptides modulate nerve development and regeneration. Reviews in the Neurosciences, 4(4), 321-364. doi:10.1515/REVNEURO.1993.4.4.321

    		•

  • Strand, F. L., Rose, K. J., Zuccarelli, L. A., Kume, J., Alves, S. E., Antonawich, F. J., & Garrett, L. Y. (1991). Neuropeptide hormones as neurotrophic factors. Physiological Reviews, 71(4), 1017-1046. This material can be found here.

  • Strand, F. L., Saint-Come, C., Lee, T. S., Lee, S. J., Kume, J., & Zuccarelli, L. A. (1993). ACTH/MSH(4-10) analog BIM 22015 aids regeneration via neurotrophic and myotrophic attributes. Peptides, 14(2), 287-296. doi:10.1016/0196-9781(93)90043-G

    		•

  • Strand, F. L., Segarra, A. C., Zuccarelli, L. A., Kume, J., & Rose, K. J. (1990). Neuropeptides as neuronal growth regulating factors. Annals of the New York Academy of Sciences, 579, 68–90. doi:10.1111/j.1749-6632.1990.tb48352.x

    		•

  • Strand, F. L., Williams, K. A., Alves, S. E., Antonawich, F. J., Lee, T. S., Lee, S. J., . . . Kume, J. (1994). Melanocortins as factors in somatic neuromuscular growth and regrowth. Pharmacology & Therapeutics, 62(1), 1-27. doi:10.1016/0163-7258(94)90002-7

    		•

  • Turner, R. C., VanGilder, R. L., Naser, Z. J., Lucke-Wold, B. P., Bailes, J. E., Matsumoto, R. R., . . . Rosen, C. L. (2014). Elucidating the severity of preclinical traumatic brain injury models: A role for functional assessment? Neurosurgery, 74(4), 382-394. doi:10.1227/NEU.0000000000000292

    		•

  • Vo, T. M., Perry, P. J., Ellerby, H. M., & Bohnert, K. (2015). Is lithium a neuroprotective agent? Annals of Clinical Psychiatry, 27(1), 49-54. This material can be found here.

  • Weizman, R., Paz, L., Peter, Y., Toren, P., & Pick, C. G. (2001). Behavioral effects of agents active at the γ-aminobutyric acid receptor complex in the staircase paradigm. Brain Research, 901(1-2), 137-142. doi:10.1016/S0006-8993(01)02331-9

    		•

  • Zasler, N. D. (2015). [Review of the book Brain injury: Applications from war and terrorism, by A. Gean (Ed.)]. Brain Injury, 29(1), 125. doi:10.3109/02699052.2014.936910

    		•

  • Zasler, N. D. (2015). Validity assessment and the neurological physical examination. NeuroRehabilitation, 36(4), 401-413. doi:10.3233/NRE-151229

    		•

  • Zuccarelli, L. A., Segarra, A. C., Kume, J., Rose, K. J., & Strand, F. L. (1990). Neuropeptides: Fail-safe, redundant or special? In D. Gupta, H. A. Wollman, & M. B. Ranke (Eds.), Neuroendocrinology: New frontiers (pp. 19-28). London, England: Brain Research Promotion.

First Prev 1 2 Next Last